Revenue (Tables)

3 Months Ended

Apr. 01, 2022

Revenue from Contract with Customer [Abstract]

Disaggregation of Revenue

The following tables present the Company’s revenues disaggregated by geographical region and revenue type for the three-month periods ended April 1, 2022 and April 2, 2021 ($ in millions). Sales taxes and other usage-based taxes collected from customers are excluded from revenue.

	Life Sciences		Diagnostics		Environmental & Applied Solutions		Total
For the Three-Month Period Ended April 1, 2022:
Geographical region:
North America	$	1,520	$	1,306	$	528	$	3,354
Western Europe	1,035		524		269		1,828
Other developed markets	222		124		32		378
High-growth markets (a)	1,105		690		333		2,128
Total	$	3,882	$	2,644	$	1,162	$	7,688
Revenue type:
Recurring	$	2,838	$	2,370	$	690	$	5,898
Nonrecurring	1,044		274		472		1,790
Total	$	3,882	$	2,644	$	1,162	$	7,688
For the Three-Month Period Ended April 2, 2021:
Geographical region:
North America	$	1,263	$	972	$	492	$	2,727
Western Europe	970		415		279		1,664
Other developed markets	225		118		29		372
High-growth markets (a)	1,088		673		334		2,095
Total	$	3,546	$	2,178	$	1,134	$	6,858
Revenue type:
Recurring	$	2,529	$	1,902	$	648	$	5,079
Nonrecurring	1,017		276		486		1,779
Total	$	3,546	$	2,178	$	1,134	$	6,858

(a) The Company defines high-growth markets as developing markets of the world experiencing extended periods of accelerated growth in gross domestic product and infrastructure which include Eastern Europe, the Middle East, Africa, Latin America and Asia (with the exception of Japan, Australia and New Zealand). The Company defines developed markets as all markets that are not high-growth markets.